RCON [Recon Technology] 10-Q/A: (Original Filing)

[FORM 10-Q/A x For the quarterly period ended September 30, 2012 ¨ For the transition period from RECON TECHNOLOGY, LTD Cayman Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) 1902 Building C, King Long International Mansion 9 Fulin Road Beijing 100107 China +86 (10) 8494-5799 x No ¨ x No ¨ Large accelerated]

By | 2016-03-13T06:37:19+00:00 February 14th, 2013|Categories: Chinese Stocks, RCON, SEC Original|Tags: , , , , , |0 Comments

SOHU [SOHU COM] SC 13G/A: (Original Filing)

[Common Stock 83408W103 December 31, 2012 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. CUSIP No.: 83408W103 1 NAME]

HIMX [Himax Technologies] SC 13G/A: (Original Filing)

[SCHEDULE 13G/A (Amendment No. 1) Himax Technologies, Inc. (Name of Issuer) ADR (Title of Class of Securities) 43289P106 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) x Rule 13d-1(b) o Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form]

By | 2016-03-23T11:51:47+00:00 February 14th, 2013|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended December 31, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director]

By | 2016-03-27T18:46:08+00:00 February 14th, 2013|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

SINA [SINA] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 2,556,470 Item 6: 0 Item 7: 3,759,762 Item 8: 0 Item 9: 3,759,762 Item 11: 5.659% Item 12: HC Cusip #G81477104 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 3,759,762 Item 8: 0 Item 9: 3,759,762 Item 11: 5.659%]

By | 2016-03-17T16:19:57+00:00 February 14th, 2013|Categories: Chinese Stocks, SEC Original, SINA|Tags: , , , , , |0 Comments
Skip to toolbar